Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary intervention.
European heart journal. Cardiovascular pharmacotherapy（2022）
摘要
Vicagrel had comparable antiplatelet effect and safety to clopidogrel in patients with CAD undergoing PCI.
更多查看译文
关键词
Clopidogrel,Coronary artery disease,Percutaneous coronary intervention,Vicagrel
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要